Supply Chain | November 12, 2021
Jubilant Biosys expands Chemistry Innovation Research Centre
The centre has an initial capacity of 500 FTEs
The centre has an initial capacity of 500 FTEs
Harvard Medical School will deliver the first customized program, ‘Accelerate’, to create the next generation of leading experts in clinical development and medical affairs
Gantenerumab is an investigational antibody in Phase III development for early Alzheimer's disease (AD) and a comprehensive data set with an expected readout in mid-2022
The new devices company will scale up its teams to create a world-class R&D centre for medical devices in India
The investment programme is expected to significantly reduce commercialisation lead times, costs and introduce more sustainable manufacturing processes
Over 61 per cent of pharmacists stated that they aim to improve their knowledge and medical skills while 76 per cent collaborated with healthcare players to improve the outcome for their patients
HTL will build, validate and operate a botulinum manufacturing facility in the US
The global CRAMS segment is expected to clock 6.2% CAGR over CY21-26E to touch US $ 170 billion
The revenues and profits derived from the new subsidiary will be consolidated in the parent company
Goal of providing 12-month internship opportunities for qualified students
Subscribe To Our Newsletter & Stay Updated
